Dynacirc Cr

Hypertensive disease

Treatment

1 FDA approval

20 Active Studies for Dynacirc Cr

What is Dynacirc Cr

Isradipine

The Generic name of this drug

Treatment Summary

Isradipine is a type of drug called a calcium channel blocker (CCB). It works by blocking the movement of calcium into cells in the heart and arteries, lowering blood pressure. Isradipine is the most powerful CCB in its class and is used to treat mild to moderate high blood pressure. It binds to calcium channels with high precision and is more selective for arterial smooth muscle cells than other CCBs.

DynaCirc

is the brand name

image of different drug pills on a surface

Dynacirc Cr Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

DynaCirc

Isradipine

1998

24

Approved as Treatment by the FDA

Isradipine, also known as DynaCirc, is approved by the FDA for 1 uses including Hypertensive disease .

Hypertensive disease

Helps manage High Blood Pressure (Hypertension)

Effectiveness

How Dynacirc Cr Affects Patients

Isradipine helps lower blood pressure by blocking calcium from entering cells. Normally, calcium enters cells and binds to calmodulin, which then starts a process that causes the cells to contract. By preventing calcium from entering the cells, isradipine stops the contraction process and causes the vessels to relax, leading to an overall decrease in blood pressure.

How Dynacirc Cr works in the body

Isradipine belongs to a class of drugs called calcium channel blockers, which are used to treat high blood pressure. It specifically targets L-type calcium channels, which are present in muscle cells and help to control contraction. Isradipine works by binding to inactive calcium channels and keeping them from activating, which can reduce the contraction of artery walls. It has extra effects on arteries compared to other calcium channel blockers, and is unlikely to affect the heart or the conduction system at therapeutic doses.

When to interrupt dosage

The endorsed dose of Dynacirc Cr is contingent upon the indicated condition. The quantity of dosage is subject to the method of delivery set forth in the below table.

Condition

Dosage

Administration

Hypertensive disease

, 2.5 mg, 5.0 mg, 10.0 mg

, Oral, Capsule, Capsule - Oral, Tablet - Oral, Tablet, Tablet, extended release - Oral, Tablet, extended release, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral

Warnings

There are 20 known major drug interactions with Dynacirc Cr.

Common Dynacirc Cr Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Isradipine.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Isradipine.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Isradipine.

Alpelisib

Major

The metabolism of Alpelisib can be decreased when combined with Isradipine.

Amifostine

Major

Isradipine may increase the hypotensive activities of Amifostine.

Dynacirc Cr Toxicity & Overdose Risk

Overdosing on isradipine can cause tiredness, an abnormally fast heartbeat, and low blood pressure. Mice and rabbits have been found to be more sensitive to the overdose, with doses of over 200mg/kg and 50mg/kg, respectively, resulting in death. Rats, however, were able to tolerate doses of up to 2000mg/kg without any negative effects on survival.

image of a doctor in a lab doing drug, clinical research

Dynacirc Cr Novel Uses: Which Conditions Have a Clinical Trial Featuring Dynacirc Cr?

18 active trials are in progress to evaluate the potential of Dynacirc Cr in providing relief for Hypertensive disease.

Condition

Clinical Trials

Trial Phases

Hypertensive disease

41 Actively Recruiting

Not Applicable, Phase 3, Phase 1, Phase 2

Dynacirc Cr Reviews: What are patients saying about Dynacirc Cr?

5

Patient Review

8/4/2012

Dynacirc Cr for High Blood Pressure

This has been the only hypertension medication that I've found to be effective with no side effects. So of course, it gets discontinued and now I'm stuck trying other meds that don't work nearly as well.

5

Patient Review

9/11/2009

Dynacirc Cr for High Blood Pressure

I have had difficulty breathing on this drug, and tried to tell the doctor it wasn't doing its job. The more I struggle to breathe, the higher my blood pressure goes.

5

Patient Review

4/9/2010

Dynacirc Cr for High Blood Pressure

The cost is unfortunately quite high, but it's worth it to me to avoid the health risks associated with not taking this medication.

4

Patient Review

9/30/2008

Dynacirc Cr for High Blood Pressure

This medicine was great for maintaining my blood pressure, but I did have some side effects like swollen ankles and feet. Unfortunately, I can't get a refill right now because the manufacturer is on hold, but my doctor has given me a replacement medication.

4

Patient Review

3/2/2008

Dynacirc Cr for High Blood Pressure

Unfortunately, this caused swelling in my ankles and feet. I'm going to have to discontinue use and try something else.

4

Patient Review

8/2/2011

Dynacirc Cr for High Blood Pressure

I find that I have to plan my trips around when I'll be taking this medication, as it causes me to need to urinate frequently and spontaneously about six to eight hours after consumption.

3.7

Patient Review

1/15/2008

Dynacirc Cr for High Blood Pressure

For the duration of the treatment, I felt flushed and hot. If I moved around too much, I'd feel dizzy and nauseous. Unfortunately, even after a month of taking it, my blood pressure was still high. So all in all, I didn't feel great and saw no results.

3.7

Patient Review

9/4/2012

Dynacirc Cr for High Blood Pressure

I take this medicine at night before bed with food. it does wake me up to go to the bathroom. thats when I feel the side effects, lightheaded, headache..tried others and couldnt take them..mfg has discontinued. so i buy it online at a much cheaper price. other meds made me very sick. so i will stay with this as long as i can.

3.7

Patient Review

9/25/2008

Dynacirc Cr for High Blood Pressure

I had to switch because the manufacturer isn't currently selling this drug.

3.7

Patient Review

2/17/2010

Dynacirc Cr for High Blood Pressure

No complaints here! This treatment was great.

3.3

Patient Review

8/27/2008

Dynacirc Cr for High Blood Pressure

I ended up in the hospital due to low sodium levels after taking this medication. I had a whole host of other symptoms, including nausea, vomiting, diarrhea, headache, and sinus problems.

3

Patient Review

11/27/2007

Dynacirc Cr for High Blood Pressure

I experienced abdominal pain, headaches, aching joints, and bloating while taking this medication. I was also taking labetolol at the time, so I'm not sure if it was the combination of the two that caused these side effects.

2.7

Patient Review

7/15/2008

Dynacirc Cr for High Blood Pressure

The constant migraines I experienced while on this medication were really scary. The side effects never went away, so I stopped taking it.

2.7

Patient Review

10/20/2007

Dynacirc Cr for High Blood Pressure

2.3

Patient Review

6/21/2008

Dynacirc Cr for High Blood Pressure

While this did help lower my blood pressure, the side effects of headaches and dizziness were really tough to deal with.

1.7

Patient Review

8/17/2009

Dynacirc Cr for High Blood Pressure

I was really disappointed when I learned that this drug is no longer available. I've had success with it in the past, and I'm struggling to find a replacement that works as well. If anyone knows why this drug is no longer available, please let me know.

1

Patient Review

8/14/2008

Dynacirc Cr for High Blood Pressure

This drug caused swelling, muscle pains and cramps. It's also been very difficult to refill my prescription since May '08. I'm getting off of this medication as soon as possible and selling the pharmaceutical stock too.

Patient Q&A Section about dynacirc cr

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is DynaCirc CR still available?

"This product is no longer being manufactured under the DynaCirc CR brand name. If the FDA has approved generic versions of this product, there may be cheaper equivalents available from other manufacturers."

Answered by AI

What is DynaCirc used for?

"Its a medication that works by blocking calcium channels in order to lower blood pressure. It can be used in tandem with a diuretic in order to maximize its effects."

Answered by AI

What class of drug is isradipine?

"Isradipine is a type of medication referred to as a calcium channel blocker. Its purpose is to relax blood vessels so that the heart doesn't have to work as hard."

Answered by AI

How long does it take for isradipine to work?

"You will not see the full benefits of this drug for 2 to 4 weeks. If you do not notice an improvement or if your blood pressure readings increase, tell your doctor."

Answered by AI

Clinical Trials for Dynacirc Cr

Image of Caridad Center, Inc. in Boynton Beach, United States.

CHW Nutrition Support for Type 2 Diabetes

18+
All Sexes
Boynton Beach, FL

This study tests whether adding CHW support to usual nutrition care helps adults with type 2 diabetes, hypertension, or chronic kidney disease manage their diet and health. At Caridad Center, a free clinic in Palm Beach County, Florida, usual care includes medical nutrition therapy from a registered dietitian and medically tailored groceries. Many patients find it hard to keep up dietary changes because of limited nutrition knowledge, cooking skills, food costs, and cultural fit. Two hundred adults will be randomly assigned to usual care or usual care plus INTEGRATE-CHW, a 12-week program of six sessions with a trained CHW. In each session the participant selects one or two goals from the dietitian's plan and builds an action plan with the CHW. The dietitian remains responsible for the nutrition plan. The study will compare nutrition self-efficacy, nutrition literacy, diet quality, food security, and clinical measures between groups at baseline and Week 12. It will also evaluate how well the program fits into routine clinic care.

Waitlist Available
Has No Placebo

Caridad Center, Inc.

Janet Diaz Martinez

Image of Satellite Healthcare - Daly City in San Francisco, United States.

Blood Pressure Management for Kidney Failure

18+
All Sexes
San Francisco, CA

The GOAL-BP pilot study will help determine whether a study comparing two blood pressure goals can be carried out in adults with end-stage kidney disease and high blood pressure who receive peritoneal dialysis. The main questions it aims to answer are whether eligible patients can be recruited for the study. Researchers will compare two goals for the top blood pressure number (systolic blood pressure): below 120 mmHg versus below 140 mmHg.This pilot study will help plan a larger trial in the future. Participants will: * Be assigned by chance to one of the two blood pressure goals. * Have their blood pressure measured at clinic visits about every two weeks. * Work with their kidney doctor on recommended changes to fluid management, peritoneal dialysis treatment, or blood pressure medicines to reach their assigned goal. * Be part of the study for about four and a half months.

Recruiting
Has No Placebo

Satellite Healthcare - Daly City (+2 Sites)

Chi-yuan Hsu, MD, MS

Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Barber and Pharmacist Coordination for High Blood Pressure

35 - 79
Male
Los Angeles, CA

The original, "Cut Your Pressure Too: The LA Barbershop Blood Pressure Study (LABBPS)" (NCT02321618) was a highly successful cluster-randomized trial of a community centered blood pressure (BP) reduction program focused on Non-Hispanic (NH) black men who experience the highest rates of hypertension (HTN) and its complications. Patrons of 52 barbershops in Los Angeles County were randomly assigned to either an intervention arm in which barbers encouraged meetings with trained clinical pharmacists who provided HTN treatment in the barbershops or a control arm in which barbers provided educational pamphlets on HTN and encouraged physician appointments. After 6 months, the intervention group had a statistically significant reduction in systolic BP (SBP) of 21.6 mmHg compared to the control group. Results were durable at 1 year. Thereafter, a pilot study (NCT03726710) aimed at improving the efficiency of the barbershop model of HTN care by substituting in-person visits with video visits once BP was at goal was undertaken in 10 hypertensive barbershop patrons. The intervention effect was unchanged. The current study represents Aim 3 of an NIH funded renewal application entitled, "Barber and Pharmacist Coordination to Improve Blood Pressure Management in Black Men." It will build upon the foundational work of the original study and telemedicine pilot by evaluating the efficacy of a fully remote hypertension management program.

Waitlist Available
Has No Placebo

Cedars-Sinai Medical Center

Christine Albert, MD, MPH

Image of Foothills Medical Center in Calgary, Canada.

Spinal Cord Stimulation for High Blood Pressure

18+
All Sexes
Calgary, Canada

High blood pressure, also called hypertension, raises the risk of heart disease, stroke, and kidney disease. Medications work well for many people, but some people still have blood pressure that stays too high, or they have side effects from their medications. Researchers are looking for treatments that do not involve taking more medication. Nerves help control blood pressure by changing how blood vessels tighten and how hard the heart pumps. Because of this, treatments that act on nerves may be able to lower blood pressure. Spinal cord stimulation is a treatment already used to manage long-term pain. It uses a small device, placed under the skin during a standard operation, that sends mild electrical signals to the spine. Laboratory studies suggest that stimulating the lower part of the mid-back may also lower blood pressure, but this has not been carefully studied in people who already use these devices. This study will look at whether changing the settings on a spinal cord stimulator affects blood pressure. About 11 adults who have high blood pressure and who already have a spinal cord stimulator for long-term pain. No new device will be placed, and no surgery or other invasive procedure will be done for this study. Participants attend a series of study visits. At each visit, trained staff record blood pressure and heart rate while the stimulator is turned on, turned off, and set to other settings that the person's care team has approved and that the person finds comfortable. There are rest breaks between each setting. Over successive visits, the study team works to identify the settings that best lower blood pressure. Participants can stop at any time, and their usual settings are restored at the end of each visit. The study will also look at whether this kind of testing is practical and comfortable for participants. The results will help researchers decide whether larger studies of spinal cord stimulation for blood pressure control are worth doing.

Waitlist Available
Has No Placebo

Foothills Medical Center

Aaron Phillips, PhD

Have you considered Dynacirc Cr clinical trials?

We made a collection of clinical trials featuring Dynacirc Cr, we think they might fit your search criteria.
Go to Trials
Image of Department of Family & Community Medicine; University of Alabama at Birmingham in Birmingham, United States.

Treatment for High Blood Pressure

18+
All Sexes
Birmingham, AL

The researchers will invite 30 patients in primary care who have high blood pressure to participate in this health program with a supportive partner of their choosing (these will be the "participant pairs"). Participant pairs will be invited to complete the Heart Care Pairs health program that will include up to six sessions each including 1) some education on a health habit like physical activity and heart healthy foods, 2) goal setting together, and 3) talk about healthy communication to support one another with heart healthy habits. The researchers will work with participants to address things that get in the way of coming for visits like offering transportation and offering telehealth visits. The researchers are seeing how this program works in real life so participants will be asked to complete as many sessions as they want to and can attend. The researchers will be interested in what participants think about the sessions, if they were satisfied with the visits, and if they would recommend the program to others in their community. The researchers will ask these questions in interviews with participants. The researchers will also ask up to 25 primary care workers about how they view the program as helpful to their work with patients with high blood pressure and whether they would refer more patients to the program in the future.

Waitlist Available
Has No Placebo

Department of Family & Community Medicine; University of Alabama at Birmingham

Image of London Health Sciences Centre (LHSC) in London, Canada.

BASIC-S Intervention for Cardiovascular Risk

18+
All Sexes
London, Canada

Vascular risk factors drive stroke, heart disease, and dementia, but translating lifestyle guidelines into routine clinical care remains challenging. To address this, we developed BASIC-S (Blood Pressure, Activity, Sleep, Interaction, Consumption, and Support), a framework targeting Blood pressure, Activity, Sleep, Interaction (socially), Consumption (nutrition), and Support using partner support and motivational interviewing. This individual-focused approach bypasses the logistical and financial barriers of complex clinical interventions by using sustained behavioral science to support gradual lifestyle changes. This study is a single-center, mixed-methods, cluster-randomized pilot trial evaluating the feasibility of the BASIC-S protocol in an occupational setting. A maximum of 60 households (120 participants) will be randomized 1:1 to either the BASIC-S intervention (motivational coaching, secure video check-ins, automated text messages, and a digital workbook) or standard care. Outcomes will assess feasibility, acceptability, and the validity of new tracking metrics to inform a future full-scale trial.

Waitlist Available
Has No Placebo

London Health Sciences Centre (LHSC)

Image of NeuroFit Lab, Ivor Wynne Centre, McMaster University in Hamilton, Canada.

Isometric Handgrip Exercise for High Blood Pressure

65+
All Sexes
Hamilton, Canada

The goal of this clinical trial is to evaluate whether a short, supervised isometric handgrip exercise program is feasible and acceptable for older adults with elevated blood pressure or hypertension. It will also explore whether this type of exercise may improve blood pressure and cognitive function. The main questions it aims to answer are: * Is this handgrip exercise program practical and acceptable for older adults to participate in within a community exercise setting? * Does participation in the program lead to changes in blood pressure and cognitive function? Researchers will compare two handgrip devices to determine whether the method of delivering the exercise influences feasibility and outcomes. Participants will: * Be randomly assigned to use one of two handgrip devices. * Complete supervised exercise sessions twice per week for 4 weeks. * Perform brief handgrip contractions at a set intensity during each session. * Complete blood pressure and cognitive assessments before and after the program.

Recruiting
Has No Placebo

NeuroFit Lab, Ivor Wynne Centre, McMaster University (+1 Sites)

Jennifer Heisz, PhD

Have you considered Dynacirc Cr clinical trials?

We made a collection of clinical trials featuring Dynacirc Cr, we think they might fit your search criteria.
Go to Trials
Image of UPMC Magee Womens Hospital in Pittsburgh, United States.

Mobile Health Program for High Blood Pressure After Preeclampsia

18+
Female
Pittsburgh, PA

Strategies targeted to optimize hypertension (HTN) control for midlife women after hypertensive disorders of pregnancy (HDP) have not been studied, despite evidence of a critical need. This proposal targets the 10-20 years postpartum as a key time when women have subclinical cardiovascular (CV) sequelae of uncontrolled HTN and are primed for CV prevention interventions. Before proceeding with large-scale intervention trials of a home blood pressure monitoring (HBPM) and coaching intervention following HDP, further pilot testing is necessary. The overarching hypothesis of this proposal is that a new monitoring and treatment paradigm utilizing HBPM combined with a virtual coaching intervention would be better than standard of care for mid-life women with prior HDP who develop HTN. Women will be assigned in an unblinded manner to the intervention or standard of care control group.

Recruiting
Has No Placebo

UPMC Magee Womens Hospital

Malamo Countouris, MD, MS

Image of UCSF Medical Center at Parnassus in San Francisco, United States.

Blood Pressure Monitoring for Atrial Fibrillation

18+
All Sexes
San Francisco, CA

The goal of this clinical trial is to learn if screening for atrial fibrillation (AFib), a common irregular heart rhythm, through daily home blood pressure monitoring will decrease the time to atrial fibrillation diagnosis in older adults with hypertension. The main question it aims to answer is: \-- Does introducing screening for AFib using a blood pressure monitor with AFib detection technology decrease time to AFib diagnosis in patients with high blood pressure, compared to usual care using a conventional home blood pressure monitor with no AFib detection? Participants will participate in two phases of the study: (1) clinical trial and (2) the registry. During the 6-month clinical trial period, participants will be asked to: * Take blood pressure measurements twice daily * Answer short weekly mobile app-based surveys * If assigned, complete continuous heart monitoring for 2 weeks and complete 1 blood test During the 12-month registry period, participants will be asked to: * Take blood pressure measurements twice daily * Answer monthly mobile app-based surveys Researchers will compare standard blood pressure measurements and AFib screening blood pressure measurements to see if there is a difference in the time to AFib diagnosis and other cardiovascular events. Participants will participate in two phases of the study: (1) trial and (2) the registry. During the 6-month trial period, participants will be asked to: * Take daily blood pressure measurements * Answer short weekly mobile app-based surveys * If assigned, complete continuous heart monitoring for 2 weeks and complete 1 blood test During the 12-month registry period, participants will be asked to: * Take daily blood pressure measurements * Answer monthly mobile app-based surveys

Waitlist Available
Has No Placebo

UCSF Medical Center at Parnassus

Gregory M Marcus, MD, MAS

Omron Healthcare Co., Ltd.

Image of Hāmākua-Kohala Health Center in Honokaa, United States.

Produce Prescription for High Blood Pressure

18+
All Sexes
Honokaa, HI

This multi-site randomized controlled trial uses a community-based approach to evaluate a Food as Medicine program for Native Hawaiian and Pacific Islander (NHPI) adults in Hawaii who have high blood pressure and difficulty affording healthy food. The study has two main goals: (1) to implement a produce prescription program and see if adding personal support from Community Health Workers (CHW) improves blood pressure among other health outcomes, and (2) to determine the program's cost-effectiveness. The study will take place across three Federally Qualified Health Centers in Hawaii. Produce prescription program participants at each site will receive $100 per month, either in the form of produce boxes or monthly vouchers to purchase fruits and vegetables, for 12 months (totaling $1200). In past studies, personal challenges (e.g., lack of transportation, lack of cooking skills) have made it difficult for participants to use the vouchers and/or the purchased produce. In other food as medicine interventions, participants have similarly faced various personal, social, and environmental barriers that limit the program's efficacy. To help participants navigate through these challenges, the investigators want to test adding 1-on-1 support from a CHW throughout the program. Other studies have found that health interventions delivered by CHWs have been effective in reducing blood pressure, blood glucose and weight, especially among vulnerable populations, such as NHPIs and those with food insecurity. The CHWs in this study will receive a training using a curriculum tailored specifically to their community and that is in alignment with the Pilinahā: The Four Connections Framework, which focuses on key connections that Indigenous people seek to attain health and can be employed to overcome health disparities. To test the effectiveness of the added CHW support, there will be two groups of participants: Group 1 (Intervention) will receive the monthly produce prescription ($100 vouchers or produce box) plus meet with a CHW every two months for support with program challenges. Group 2 (Control) will receive the same monthly produce prescription, but will not have meetings with a CHW. The investigators want to see if the added support from CHWs leads to better blood pressure results, among other health outcomes. Upon providing informed consent and enrolling into the program, produce prescription program participants will: * Attend 5 study visits over the one year program. These happen at the start, and then at 3, 6, 9, and 12 months. * Complete health checks at the first visit. This includes getting a home blood pressure monitor and learning about heart health and nutrition. Staff will measure height, weight, waist size, and blood pressure. * Answer surveys about their demographic background, health habits, diet, and culture. * Receive $100 in vouchers every month for 12 months to redeem for fruits and vegetables at a local retailer. * Group 1 will additionally meet with a CHW every two months for 1-on-1 support with any challenges related to the program. * Group 2 will receive monthly reminders to use their vouchers but no CHW meetings. After the program ends, researchers will analyze the financial value of the intervention. This involves calculating the total cost to run the program (including vouchers, CHW training and salaries, and administrative costs) and comparing it to potential savings in healthcare costs. By looking at improvements in blood pressure, researchers can estimate how many heart-related health problems were prevented and how much money was saved on medical care.

Waitlist Available
Has No Placebo

Hāmākua-Kohala Health Center (+2 Sites)

Have you considered Dynacirc Cr clinical trials?

We made a collection of clinical trials featuring Dynacirc Cr, we think they might fit your search criteria.
Go to Trials